The strategist expects that the fundamental earnings strength underpinning his original thesis will hold, betting Trump’s reversals on tariffs will limit any market or economic fallout.
Related Posts
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
It comes as drugmakers brace for Trump’s levies on pharmaceuticals imported into the U.S. – his administration’s bid to boost manufacturing in the country.
Asian economies scramble to appease Trump as the U.S. president ratchets up tariff threats
Asian economies are striving to avert Trump tariffs as they have hefty trade surpluses with the U.S. and levy much higher duties on imports from […]
Baird downgrades shares of Rivian, cites ‘sluggish’ EV sales and Trump policies
A tougher electric vehicle outlook in 2025 is leading Baird to step to the sidelines on this EV startup.